B6;129P2-Plxnb1tm1Matl/Ieg

Status

Available to order

EMMA IDEM:03099
Citation informationRRID:IMSR_EM:03099 

Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information.

International strain nameB6;129P2-Plxnb1tm1Matl/Ieg
Alternative namePlexin-B1 KO
Strain typeTargeted Mutant Strains : Knock-in
Allele/Transgene symbolPlxnb1tm1Matl
Gene/Transgene symbolPlxnb1

Information from provider

ProviderRoland Friedel
Provider affiliationSoriano Lab, Department of Developomental & Regenerative Biology, Mount Sinai School of Medicine
Genetic informationOfficial allele name: Plxnb1tm1Matl. Knock-out by targeted trapping of the plexin B1 gene. Targeted mutagenesis using a promoterless gene trap vector ("targeted trapping") was used to insert a 9.4-kb placental alkaline phosphatase (PLAP) secretory cassette into intron 21. This results in transcription of a fusion mRNA joining upstream exons of the endogenous gene to the elements of the cassette, comprising a splice acceptor and a transmembrane domain coding sequence followed by the betageo (lacZ/neomycin resistance fusion) cDNA, an internal ribosomal entry site (IRES), and the human PLAP sequence with a polyadenylation signal. Two proteins are translated from this bicistronic transcript: a PLXNB1/Betageo fusion protein that is sequestered in an intracellular compartment of the neuronal cell body; and PLAP, which is expressed on the axonal surface.
Phenotypic informationHomozygous viable and fertile. Plxnb1-/- embryonic kidneys are larger in size and have increased ureteric branching. Plexin B1/plexin B2 double mutants are early embryonic lethal.
References
  • Gene targeting using a promoterless gene trap vector ("targeted trapping") is an efficient method to mutate a large fraction of genes.;Friedel Roland H, Plump Andrew, Lu Xiaowei, Spilker Kerri, Jolicoeur Christine, Wong Karen, Venkatesh Tadmiri R, Yaron Avraham, Hynes Mary, Chen Bin, Okada Ami, McConnell Susan K, Rayburn Helen, Tessier-Lavigne Marc, ;2005;Proceedings of the National Academy of Sciences of the United States of America;102;13188-93; 16129827
  • Plexin-B2, but not Plexin-B1, critically modulates neuronal migration and patterning of the developing nervous system in vivo.;Deng Suhua, Hirschberg Alexandra, Worzfeld Thomas, Penachioni Junia Y, Korostylev Alexander, Swiercz Jakub M, Vodrazka Peter, Mauti Olivier, Stoeckli Esther T, Tamagnone Luca, Offermanns Stefan, Kuner Rohini, ;2007;The Journal of neuroscience : the official journal of the Society for Neuroscience;27;6333-47; 17554007
  • A functional role for semaphorin 4D/plexin B1 interactions in epithelial branching morphogenesis during organogenesis.;Korostylev Alexander, Worzfeld Thomas, Deng Suhua, Friedel Roland H, Swiercz Jakub M, Vodrazka Peter, Maier Viola, Hirschberg Alexandra, Ohoka Yoshiharu, Inagaki Shinobu, Offermanns Stefan, Kuner Rohini, ;2008;Development (Cambridge, England);135;3333-43; 18799546
Homozygous fertileyes
Homozygous viableyes
Homozygous matings requiredno
Immunocompromisedno

Information from EMMA

Archiving centreHelmholtz Zentrum Muenchen - German Research Center for Environmental Health (GmbH), Oberschleißheim, Germany
Animals used for archivingheterozygous C57BL/6J males, wild-type C57BL/6J females
Stage of embryos2-cell

Disease and phenotype information

MGI phenotypes (allele matching)
  • no phenotypic analysis / MGI
  • nervous system phenotype / MGI
MGI phenotypes (gene matching)
  • no abnormal phenotype detected / MGI
  • no phenotypic analysis / MGI
  • enlarged kidney / MGI
  • nervous system phenotype / MGI
  • vision/eye phenotype / MGI
  • abnormal branching involved in ureteric bud morphogenesis / MGI
  • abnormal metanephros morphology / MGI

Literature references

  • Gene targeting using a promoterless gene trap vector ("targeted trapping") is an efficient method to mutate a large fraction of genes.;Friedel Roland H, Plump Andrew, Lu Xiaowei, Spilker Kerri, Jolicoeur Christine, Wong Karen, Venkatesh Tadmiri R, Yaron Avraham, Hynes Mary, Chen Bin, Okada Ami, McConnell Susan K, Rayburn Helen, Tessier-Lavigne Marc, ;2005;Proceedings of the National Academy of Sciences of the United States of America;102;13188-93; 16129827
  • Plexin-B2, but not Plexin-B1, critically modulates neuronal migration and patterning of the developing nervous system in vivo.;Deng Suhua, Hirschberg Alexandra, Worzfeld Thomas, Penachioni Junia Y, Korostylev Alexander, Swiercz Jakub M, Vodrazka Peter, Mauti Olivier, Stoeckli Esther T, Tamagnone Luca, Offermanns Stefan, Kuner Rohini, ;2007;The Journal of neuroscience : the official journal of the Society for Neuroscience;27;6333-47; 17554007
  • A functional role for semaphorin 4D/plexin B1 interactions in epithelial branching morphogenesis during organogenesis.;Korostylev Alexander, Worzfeld Thomas, Deng Suhua, Friedel Roland H, Swiercz Jakub M, Vodrazka Peter, Maier Viola, Hirschberg Alexandra, Ohoka Yoshiharu, Inagaki Shinobu, Offermanns Stefan, Kuner Rohini, ;2008;Development (Cambridge, England);135;3333-43; 18799546

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen embryos. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Genotyping protocol

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
For this strain no provider MTA is needed. Distribution is based on the EMMA conditions only.

EMMA conditions
Legally binding conditions for the transfer

Right strain for your research?

The information provided on this page is, to the best of EMMA’s knowledge, based on data supplied by the original provider. End users are responsible for reviewing these details and for validating the strain and its suitability for their experimental use.​
Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).